Cargando…
The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya
BACKGROUND: Lymphatic filariasis (LF), a neglected tropical disease (NTD) and leading cause of global disability, is endemic in 32 countries in Africa with almost 350 million people requiring regular drug administration, and only 16 countries achieving target coverage. Community Drug Distributors (C...
Autores principales: | Kusi, Caroline, Steinmann, Peter, Merten, Sonja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050125/ https://www.ncbi.nlm.nih.gov/pubmed/32114985 http://dx.doi.org/10.1186/s40249-020-0638-1 |
Ejemplares similares
-
Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya
por: Njomo, Doris W., et al.
Publicado: (2020) -
Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya
por: Njenga, Sammy M., et al.
Publicado: (2017) -
WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM
NORTHERN COASTAL TANZANIA
por: PARKER, MELISSA, et al.
Publicado: (2013) -
Addressing barriers of community participation and access to mass drug administration for lymphatic filariasis elimination in Coastal Kenya using a participatory approach
por: Njomo, Doris W., et al.
Publicado: (2020) -
A mixed-methods exploration into the resilience of community drug distributors conducting mass drug administration for preventive chemotherapy of lymphatic filariasis and onchocerciasis in Côte d’Ivoire and Uganda
por: Dilliott, Daniel, et al.
Publicado: (2022)